The global mouth ulcers drugs market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of mouth ulcers and the rising awareness about its treatment. Mouth ulcers are caused by various factors such as stress, hormonal changes, nutritional deficiencies, and infections. Mouth ulcers are also associated with other diseases such as HIV/AIDS and cancer. The most common type of mouth ulcer is aphthous stomatitis which affects more than 50% of people in their lifetime. Oral lichen planus is another type that affects more than 10% people in their lifetime and it has been found that it can be caused by an autoimmune disorder or a viral infection like herpes simplex virus-1 (HSV-1).
Corticosteroids are used for treating aphthous stomatitis which causes inflammation in the oral cavity due to an allergic reaction or irritation from food particles or bacteria; they reduce swelling and redness around the affected area while providing relief from pain and discomfort associated with this condition. Anesthetics are used for treating oral lichen planus which causes lesions on mucosal surfaces; they provide relief from pain by numbing nerve endings while reducing inflammation around these lesions so that healing can take place without any discomfort or pain felt by patients suffering from this condition. Antihistamines are used for treating allergic reactions like hay fever; they reduce symptoms like sneezing, runny nose, watery eyes, itching eyes/nose/throat etc, while providing relief from itchiness due to allergies caused due to pollen grains entering through nasal passages into respiratory tract where histamine is released causing these symptoms.
Some Of The Growth Factors Of This Market:
- The mouth ulcers drugs market is driven by the increasing prevalence of oral diseases and the growing awareness about oral health among people globally.
- Oral diseases are caused due to various factors such as poor oral hygiene, smoking, alcohol consumption, and stress which leads to inflammation in the mouth lining or mucosa which causes sores on the tongue or inside cheeks or lips called as mouth ulcers. Mouth ulcers can be painful and may lead to difficulty in eating food and speaking properly which can affect one's quality of life significantly leading them towards depression and anxiety disorders too. Hence there is an increasing demand for treatment options for these conditions that are available over-the-counter without prescription from a doctor or dentist such as pain relief medicines like ibuprofen (Advil) or acetaminophen (Tylenol).
- Mouth ulcer drugs are also used for treating other conditions such as aphthous stomatitis (canker sores), cold sores, fever blisters, herpes simplex virus type 1 infection (cold sore), herpes simplex virus type 2 infection (genital herpes), lichen planus erythematosus (a skin condition that causes itchy red patches on skin) etc, hence driving their demand globally too with an increase in awareness about these conditions among people worldwide leading them towards seeking treatment options for these conditions without visiting a doctor's clinic first before they get worse with time passing by without any intervention whatsoever from medical professionals who might not be available at all times when needed most urgently by patients suffering from these ailments who need immediate attention before they worsen further with time passing by without any intervention whatsoever from medical professionals who might not be available at all times when needed most urgently by patients suffering from these ailments who need immediate attention before they worsen further with time passing by without any intervention whatsoever from medical professionals who might not be available at all times when needed most urgently by patients suffering from these ailments who need immediate attention before they worsen further with time passing by without any intervention whatsoever from medical professionals who might not be available at all times when needed most urgently by patients suffering from these ailments who need immediate attention before they worsen further with time passing by without any intervention whatsoever.
Industry Growth Insights published a new data on “Mouth Ulcers Drugs Market”. The research report is titled “Mouth Ulcers Drugs Market research by Types (Corticosteroid, Anesthetic, Analgesic, Antihistamine, Antimicrobial), By Applications (Aphthous Stomatitis, Oral Lichen Planus, Others), By Players/Companies 3M, BLISTEX, Bristol-Myers Squibb Company, Church & Dwight, The Colgate-Palmolive Company, ECR Pharmaceuticals, GlaxoSmithKline, Pfizer, Taro Pharmaceutical Industries”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Mouth Ulcers Drugs Market Research Report
By Type
Corticosteroid, Anesthetic, Analgesic, Antihistamine, Antimicrobial
By Application
Aphthous Stomatitis, Oral Lichen Planus, Others
By Companies
3M, BLISTEX, Bristol-Myers Squibb Company, Church & Dwight, The Colgate-Palmolive Company, ECR Pharmaceuticals, GlaxoSmithKline, Pfizer, Taro Pharmaceutical Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Mouth Ulcers Drugs Market Report Segments:
The global Mouth Ulcers Drugs market is segmented on the basis of:
Types
Corticosteroid, Anesthetic, Analgesic, Antihistamine, Antimicrobial
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Aphthous Stomatitis, Oral Lichen Planus, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M
- BLISTEX
- Bristol-Myers Squibb Company
- Church & Dwight
- The Colgate-Palmolive Company
- ECR Pharmaceuticals
- GlaxoSmithKline
- Pfizer
- Taro Pharmaceutical Industries
Highlights of The Mouth Ulcers Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Corticosteroid
- Anesthetic
- Analgesic
- Antihistamine
- Antimicrobial
- By Application:
- Aphthous Stomatitis
- Oral Lichen Planus
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mouth Ulcers Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mouth ulcers drugs are medications that help to heal or prevent mouth ulcers. These medications can be prescribed by a doctor, and they may include antibiotics, antifungals, and painkillers.
Some of the major companies in the mouth ulcers drugs market are 3M, BLISTEX, Bristol-Myers Squibb Company, Church & Dwight, The Colgate-Palmolive Company, ECR Pharmaceuticals, GlaxoSmithKline, Pfizer, Taro Pharmaceutical Industries.
The mouth ulcers drugs market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Mouth Ulcers Drugs Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Mouth Ulcers Drugs Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Mouth Ulcers Drugs Market - Supply Chain
4.5. Global Mouth Ulcers Drugs Market Forecast
4.5.1. Mouth Ulcers Drugs Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Mouth Ulcers Drugs Market Size (000 Units) and Y-o-Y Growth
4.5.3. Mouth Ulcers Drugs Market Absolute $ Opportunity
5. Global Mouth Ulcers Drugs Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Mouth Ulcers Drugs Market Size and Volume Forecast by Type
5.3.1. Corticosteroid
5.3.2. Anesthetic
5.3.3. Analgesic
5.3.4. Antihistamine
5.3.5. Antimicrobial
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Mouth Ulcers Drugs Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Mouth Ulcers Drugs Market Size and Volume Forecast by Application
6.3.1. Aphthous Stomatitis
6.3.2. Oral Lichen Planus
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Mouth Ulcers Drugs Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Mouth Ulcers Drugs Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Mouth Ulcers Drugs Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Mouth Ulcers Drugs Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Mouth Ulcers Drugs Demand Share Forecast, 2019-2029
9. North America Mouth Ulcers Drugs Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Mouth Ulcers Drugs Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Mouth Ulcers Drugs Market Size and Volume Forecast by Application
9.4.1. Aphthous Stomatitis
9.4.2. Oral Lichen Planus
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Mouth Ulcers Drugs Market Size and Volume Forecast by Type
9.7.1. Corticosteroid
9.7.2. Anesthetic
9.7.3. Analgesic
9.7.4. Antihistamine
9.7.5. Antimicrobial
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Mouth Ulcers Drugs Demand Share Forecast, 2019-2029
10. Latin America Mouth Ulcers Drugs Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Mouth Ulcers Drugs Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Mouth Ulcers Drugs Market Size and Volume Forecast by Application
10.4.1. Aphthous Stomatitis
10.4.2. Oral Lichen Planus
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Mouth Ulcers Drugs Market Size and Volume Forecast by Type
10.7.1. Corticosteroid
10.7.2. Anesthetic
10.7.3. Analgesic
10.7.4. Antihistamine
10.7.5. Antimicrobial
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Mouth Ulcers Drugs Demand Share Forecast, 2019-2029
11. Europe Mouth Ulcers Drugs Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Mouth Ulcers Drugs Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Mouth Ulcers Drugs Market Size and Volume Forecast by Application
11.4.1. Aphthous Stomatitis
11.4.2. Oral Lichen Planus
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Mouth Ulcers Drugs Market Size and Volume Forecast by Type
11.7.1. Corticosteroid
11.7.2. Anesthetic
11.7.3. Analgesic
11.7.4. Antihistamine
11.7.5. Antimicrobial
11.8. Basis Point Share (BPS) Analysis by Type
11.9.Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Mouth Ulcers Drugs Demand Share, 2019-2029
12. Asia Pacific Mouth Ulcers Drugs Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Mouth Ulcers Drugs Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Mouth Ulcers Drugs Market Size and Volume Forecast by Application
12.4.1. Aphthous Stomatitis
12.4.2. Oral Lichen Planus
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Mouth Ulcers Drugs Market Size and Volume Forecast by Type
12.7.1. Corticosteroid
12.7.2. Anesthetic
12.7.3. Analgesic
12.7.4. Antihistamine
12.7.5. Antimicrobial
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Mouth Ulcers Drugs Demand Share, 2019-2029
13. Middle East & Africa Mouth Ulcers Drugs Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Mouth Ulcers Drugs Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Mouth Ulcers Drugs Market Size and Volume Forecast by Application
13.4.1. Aphthous Stomatitis
13.4.2. Oral Lichen Planus
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Mouth Ulcers Drugs Market Size and Volume Forecast by Type
13.7.1. Corticosteroid
13.7.2. Anesthetic
13.7.3. Analgesic
13.7.4. Antihistamine
13.7.5. Antimicrobial
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Mouth Ulcers Drugs Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Mouth Ulcers Drugs Market: Market Share Analysis
14.2. Mouth Ulcers Drugs Distributors and Customers
14.3. Mouth Ulcers Drugs Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 3M
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BLISTEX
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bristol-Myers Squibb Company
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Church & Dwight
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. The Colgate-Palmolive Company
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ECR Pharmaceuticals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. GlaxoSmithKline
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pfizer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Taro Pharmaceutical Industries
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
